|
FUNDC2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.91700000318207E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.10239986215322E-10 |
| Normal-vs-Stage2 |
1.538440E-01 |
| Normal-vs-Stage3 |
6.835300E-04 |
| Normal-vs-Stage4 |
1.504450E-03 |
| Stage1-vs-Stage2 |
2.338200E-01 |
| Stage1-vs-Stage3 |
1.496760E-01 |
| Stage1-vs-Stage4 |
5.902600E-01 |
| Stage2-vs-Stage3 |
6.714800E-01 |
| Stage2-vs-Stage4 |
5.172600E-01 |
| Stage3-vs-Stage4 |
7.064200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.0540996094669E-10 |
| Normal-vs-AfricanAmerican |
3.799700E-04 |
| Normal-vs-Asian |
3.734000E-01 |
| Caucasian-vs-AfricanAmerican |
1.241820E-01 |
| Caucasian-vs-Asian |
3.921800E-01 |
| AfricanAmerican-vs-Asian |
8.670400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.22779572567333E-11 |
| Normal-vs-Female |
8.584400E-03 |
| Male-vs-Female |
8.27449999962759E-07 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.430260E-04 |
| Normal-vs-Extreme_Weight |
9.70330005234388E-09 |
| Normal-vs-Obese |
2.10409999999994E-05 |
| Normal-vs-Extreme_Obese |
2.34449999999553E-05 |
| Normal_Weight-vs-Extreme_Weight |
3.789600E-01 |
| Normal_Weight-vs-Obese |
9.172600E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.328200E-01 |
| Extreme_Weight-vs-Obese |
2.625400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.044200E-01 |
| Obese-vs-Extreme_Obese |
4.273600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.223900E-02 |
| Normal-vs-Age(41-60Yrs) |
2.11230000046747E-07 |
| Normal-vs-Age(61-80Yrs) |
2.88850054985801E-10 |
| Normal-vs-Age(81-100Yrs) |
6.204300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.374000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.542180E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.872200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.266180E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.888400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.275800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.80440173492525E-11 |
| Normal-VS-Type2 PRCC |
3.67789999999868E-05 |
| Normal-VS-KIRP CIMP |
9.541700E-02 |
| Normal-VS-Unclassified PRCC |
4.29199999996133E-06 |
| Type1 PRCC-VS-Type2 PRCC |
2.341800E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.174410E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.192200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.641800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.121800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.394000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.335600E-03 |
| Normal-vs-N1 |
2.15630000521827E-08 |
| Normal-vs-N2 |
5.909800E-01 |
| N0-vs-N1 |
5.635500E-02 |
| N0-vs-N2 |
1.875810E-01 |
| N1-vs-N2 |
6.193300E-04 |
|
|
